Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. - Wikidata - wikimedia - TriplyDB

Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.

Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.

http://www.wikidata.org/entity/Q34691699

about

Early interventions in risk groups for schizophrenia: what are we waiting for?Stress weakens prefrontal networks: molecular insults to higher cognition Attachment, Neurobiology, and Mentalizing along the Psychosis Continuum Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive Disorders How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis Schizophrenia risk from complex variation of complement component 4 Motion-related artifacts in structural brain images revealed with independent estimates of in-scanner head motion Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sample Alterations in the hippocampus and thalamus in individuals at high risk for psychosis.Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia.N100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic Youth.The Function Biomedical Informatics Research Network Data Repository Brain imaging during the transition from psychosis prodrome to schizophrenia.Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study A critique of the "ultra-high risk" and "transition" paradigm.Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study.Evolution of structural abnormalities in the rat brain following in utero exposure to maternal immune activation: A longitudinal in vivo MRI study.SchizConnect: Mediating neuroimaging databases on schizophrenia and related disorders for large-scale integration.Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis.Chronic Stimulation of Alpha-2A-Adrenoceptors With Guanfacine Protects Rodent Prefrontal Cortex Dendritic Spines and Cognition From the Effects of Chronic Stress Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders Paliperidone Protects SH-SY5Y Cells Against MK-801-Induced Neuronal Damage Through Inhibition of Ca(2+) Influx and Regulation of SIRT1/miR-134 Signal Pathway.Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers.Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study Delinquency, depression, and psychosis among adolescents in foster care: what holds three heads together?Functional Connectivity Anomalies in Adolescents with Psychotic Symptoms Connectome-wide network analysis of youth with Psychosis-Spectrum symptoms.Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies.Microglial activation and progressive brain changes in schizophrenia.Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis Dynamic endophenotypes and longitudinal trajectories: capturing changing aspects of development in early psychosis.Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.Is neuroimaging clinically useful in subjects at high risk for psychosis?Brain Biomarkers of Vulnerability and Progression to Psychosis

P2860

Q26747545-9831522D-DBF7-46DD-B0F2-205E3CBF6C7B Q26781227-95BF3793-CC09-4320-961D-1F54DF8A128D Q28069770-064ED25F-F0C2-4DFE-9CCB-16BEDE076A62 Q28076907-6770ABBD-F806-4CA3-8969-8DD2CBCAB217 Q28087255-EE62479B-2D52-47CA-93E8-EEF0C8A2EDFB Q28272545-5F6C1E2D-AE82-415B-B052-A8A0D7EC33BD Q28583749-F5208E38-E458-4639-A8E7-0C91D8A4150D Q30236016-2F4EA92E-183E-42CB-BDBE-872562050EA0 Q30357824-EFF10A53-BD05-4B41-9ADB-DD3A2319265E Q30368928-676F01A3-0F5A-491E-AD34-1A66DE7E8A61 Q30381309-F463ED43-B285-4560-B51B-4754F419881D Q30383068-2FB07837-28FC-404A-BA25-B6DAB9529691 Q30391026-6F0342BB-12E8-4D2E-81F3-9E8F391FA9F5 Q30679446-B237AAAF-1905-4E6A-8AE0-0967CEE1038A Q30938447-416722CB-C980-40B2-AFEF-A34F901C8F04 Q33635522-2AF1F894-72B6-4C0E-B909-FC5F55DDE16D Q33670654-26971C26-65B5-45E9-B30F-728F9905E1B9 Q33707483-7A6FFA37-033B-44EB-B8D0-A49BE1BF250F Q33718930-A1083310-8FAF-40EB-90DB-83875FDF03FC Q34483469-4E52F4A2-A43E-4FC5-BEFB-7AFDF343C4BE Q34681347-C47128DE-2DFE-4F9D-A09A-1C527097AFB7 Q35046682-E4860946-DD10-4C4D-87BB-4F9811254385 Q35603078-68B5BFB9-32DC-4525-82F1-4A4072ABF92B Q35621468-8EFF9BE9-8D2E-431D-BB2A-8E335A316F18 Q35657340-7DC95034-DE7F-4202-BE48-A6B06E3CA10F Q36066670-846917EC-0DDF-4D8D-B66B-D74D70D80EB8 Q36148454-2231C8E8-4DC5-4EDC-8B16-7D0B45C43919 Q36216975-47486EA4-A00B-415D-A288-FB11F233F9DC Q36260876-50C7F321-D727-428B-8DE9-61C73AAF811B Q36296795-18D9D934-2E51-47AD-BFE7-D650607397A8 Q36348922-788F8C7F-1863-4945-B69A-812E900BA7E1 Q36546971-0FFA2E0F-127A-4452-AD83-2C8BC7DE6C39 Q36665332-1CA51CC9-C201-4CB7-90DA-6D42085BE609 Q36683838-72FDA867-B177-4CCF-B6AD-2040F113C7AD Q36766806-FF56C594-7E43-49B8-9EED-320C860E4E9D Q36813471-7DD5B16A-491B-4507-8F95-DEA351C747E8 Q36858411-BEFCBEC6-B781-45DE-8CD6-6E5DB0C8616B Q36910682-67F11AF3-ED5D-4A3D-9AB7-636882170879 Q37015339-48EC9A52-8D79-40B8-9B3E-A499A4A1ACBF Q37124940-791E9BBC-22E0-4DDA-AD7F-1DF114807F21

P2860

Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.

http://www.wikidata.org/entity/Q34691699

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Progressive reduction in corti ...... uth at elevated clinical risk.

@ast

Progressive reduction in corti ...... uth at elevated clinical risk.

@en

Progressive reduction in corti ...... uth at elevated clinical risk.

@nl

type

label

Progressive reduction in corti ...... uth at elevated clinical risk.

@ast

Progressive reduction in corti ...... uth at elevated clinical risk.

@en

Progressive reduction in corti ...... uth at elevated clinical risk.

@nl

prefLabel

Progressive reduction in corti ...... uth at elevated clinical risk.

@ast

Progressive reduction in corti ...... uth at elevated clinical risk.

@en

Progressive reduction in corti ...... uth at elevated clinical risk.

@nl

P1433

Q34691699-1A77B14E-CF1E-49A5-B7A6-78BD04FE688E

P1476

Q34691699-C45E81E2-8386-415C-AF94-5C65D42D42D7

P2093

Q34691699-0188192F-09FB-4AC7-AF1F-B33A5EE6205C

Q34691699-0694600C-F313-4DC7-B532-E910501154FB

Q34691699-09CCB158-ECF3-4F20-A71A-95A2D3A84CD9

Q34691699-1812D738-F675-4379-AD25-DFF121F14D7E

Q34691699-2046777A-1AF5-495A-B591-C271130C3D2C

Q34691699-231712EA-AB29-4A81-A917-42EB2DA6189F

Q34691699-62868220-F5F6-4725-8754-992F7C64DE7E

Q34691699-6586B727-58DD-42E9-8A30-73407192C550

Q34691699-76249DFC-4843-47E1-B13D-6C419CD163D3

Q34691699-8D5F8615-9190-4C1B-BF60-F2F5472D690A

P2860

Q34691699-01E18B82-CBAD-46D5-8CA2-732328AB290E

Q34691699-042C9821-A041-4763-9952-4E70D379543E

Q34691699-0533D82D-C06F-406F-BB95-0AB4C4D0680E

Q34691699-0F2FAA37-7B52-43E3-8239-2CB6AD5BCB7E

Q34691699-2077A2C4-910A-4951-AF88-72381AAE082C

Q34691699-24A348B4-D296-4164-B8D1-D6DF179BC488

Q34691699-25416232-88B8-40CF-8EC6-E2D00E19BB21

Q34691699-25625474-4C6C-4171-9C03-411EEFBCC611

Q34691699-2AAA634F-FA0F-4D0E-908F-5A19E0DA528F

Q34691699-2BFBD6D3-87C9-4C20-9B02-0A65DA9B7658

P304

Q34691699-FE1067E3-BCE0-4381-A00E-A2DEDEC93122

P31

Q34691699-02D54739-2172-4DCC-8867-CDDFF4D4EA6E

P356

Q34691699-BE69DACF-28A4-47E9-B51E-EAAD02EBF6D2

P407

Q34691699-698B25D7-53F2-4FA8-89E3-580A8187B6F2

P433

Q34691699-48D853C1-5927-42C2-A753-5E3CDDF3F9EC

P478

Q34691699-9C3C4678-0F84-4744-9B73-158973E4E937

P50

Q34691699-576F4C5C-3C07-4BB7-A5A4-EB0DDE7E2C15

Q34691699-759A2959-EDA8-466E-B19F-0405E301E222

Q34691699-CC93E666-32CA-46B9-A151-152C2D0FFFB4

Q34691699-D1DEC138-0F29-4038-82DF-5B901BE6024E

Q34691699-FACD09FC-00AB-45DD-9F9C-D420FCC0774A

P577

Q34691699-AAA9B3A9-8281-436C-95C2-D47CBCED6F3E

P698

Q34691699-57D01779-C0CA-4943-8C66-EAAD9978A0F1

P921

Q34691699-2E889595-DF72-4CDF-A88E-9070B69FFB65

Q34691699-304E3211-D70A-4B84-98E9-39A06C155065

Q34691699-73FED997-166C-4E46-8E3C-8B8EDDA1A3AB

P932

Q34691699-E028640B-76FA-42E6-AE65-79CFA3D2CB70

P356

J.BIOPSYCH.2014.05.023

P1433

Biological Psychiatry

P1476

Progressive reduction in corti ...... uth at elevated clinical risk.

@en

P2093

Aron Jacobson

http://www.w3.org/2001/XMLSchema#string

Barbara Cornblatt

http://www.w3.org/2001/XMLSchema#string

Carrie E Bearden

http://www.w3.org/2001/XMLSchema#string

Clark Jeffries

http://www.w3.org/2001/XMLSchema#string

Daniel H Mathalon

http://www.w3.org/2001/XMLSchema#string

Daqiang Sun

http://www.w3.org/2001/XMLSchema#string

Diana Perkins

http://www.w3.org/2001/XMLSchema#string

Elaine Walker

http://www.w3.org/2001/XMLSchema#string

George He

http://www.w3.org/2001/XMLSchema#string

Ming Tsuang

http://www.w3.org/2001/XMLSchema#string

P2860

Structural brain alterations in individuals at ultra-high risk for psychosis: a review of magnetic resonance imaging studies and future directions

Dendritic spine pathology in schizophrenia

Cortical Surface-Based Analysis

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system

Automatically parcellating the human cerebral cortex

Measuring the thickness of the human cerebral cortex from magnetic resonance images

Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Measurement of MRI scanner performance with the ADNI phantom.

P304

147-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2014.05.023

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P50

Thomas McGlashan

Kristin S Cadenhead

Larry J Seidman

P577

2014-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25034946

http://www.w3.org/2001/XMLSchema#string

P921

cortical thickness

P932

4264996

http://www.w3.org/2001/XMLSchema#string